NASDAQ: CLYM
Climb Bio Inc Stock Ownership - Who owns Climb Bio?

Insider buying vs selling

Have Climb Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Aoife BrennanPresident and CEO2025-06-3020,618$1.22
$25.15kSell
Emily PimblettSVP Finance CAO2025-06-201,242$1.24
$1.54kSell
Emily PimblettSVP Finance CAO2025-03-201,199$1.31
$1.57kSell
Emily PimblettCHIEF ACCOUNTING OFFICER2024-12-191,235$2.02
$2.49kSell
Emily PimblettCHIEF ACCOUNTING OFFICER2024-09-209$8.06
$72.54Sell
Emily PimblettCHIEF ACCOUNTING OFFICER2024-09-201,182$8.18
$9.67kSell

1 of 1

CLYM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLYM insiders and whales buy or sell their stock.

CLYM Shareholders

What type of owners hold Climb Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP46.37%31,419,267$72.26MInstitution
Ai Eti LLC7.39%5,009,400$11.52MInsider
Cantor Fitzgerald L P3.69%2,502,531$5.76MInstitution
Citigroup Inc2.38%1,611,887$3.71MInstitution
Affinity Asset Advisors LLC2.21%1,500,000$3.45MInstitution
Vanguard Group Inc1.96%1,331,250$3.06MInstitution
Deep Track Capital LP1.53%1,040,115$2.39MInstitution
Kynam Capital Management LP1.52%1,028,341$2.37MInstitution
Tang Capital Management LLC1.48%1,000,000$2.30MInstitution
Blackrock Inc1.30%877,969$2.02MInstitution

1 of 3

CLYM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLYM73.63%9.49%Net SellingNet Selling
NKTX62.30%37.70%Net SellingNet Selling
THTX26.27%0.00%
OBIO33.61%64.94%Net BuyingNet Buying
ELDN57.27%42.73%

Climb Bio Stock Ownership FAQ

Who owns Climb Bio?

Climb Bio (NASDAQ: CLYM) is owned by 73.63% institutional shareholders, 9.49% Climb Bio insiders, and 16.88% retail investors. Ai Eti LLC is the largest individual Climb Bio shareholder, owning 5.01M shares representing 7.39% of the company. Ai Eti LLC's Climb Bio shares are currently valued at $11.17M.

If you're new to stock investing, here's how to buy Climb Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.